| Literature DB >> 31040455 |
Furkhan Ali1, Gopi Gajera2, Guru S Gowda1, Preeti Srinivasa3, Mahesh Gowda2.
Abstract
Consent is a process that allows for free expression of an informed choice, by a competent individual. The consent is considered as one of the important components of health-care delivery and biomedical research today. Informed consent involves clinical, ethical, and legal dimensions and is believed to uphold an individual's autonomy and the right to choose. It is very important in Indian mental health care as the Mental Healthcare Act (MHCA) 2017 mandates informed consent in admission, treatment, discharge planning, and research intervention/procedures. In 2017, the Indian Council of Medical Research laid down the National Ethical Guidelines for BioMedical and Health Research involving Human Participant for research protocols, which the MHCA advocates. This article gives an overview on the evaluation of consent in clinical practice and also highlights the approach and challenge in psychiatric practice in India.Entities:
Keywords: Consent; Ethics; India; Law; Psychiatry
Year: 2019 PMID: 31040455 PMCID: PMC6482676 DOI: 10.4103/psychiatry.IndianJPsychiatry_163_19
Source DB: PubMed Journal: Indian J Psychiatry ISSN: 0019-5545 Impact factor: 1.759
Type of admission and consenting person
| Section | Details | Consenting person | Inform to MHRB |
|---|---|---|---|
| Section 86 | Independent admission and treatment | PMI himself | No need to inform MHRB |
| Section 87 | Admission of minor | Guardian/Nominated Representative | Inform the board within 72 h |
| Section 89 | Admission and treatment of persons with mental illness, with high support needs, in mental health establishment, up to 30 days (supported admission) | Nominated representative | Inform the board within 72 h in case of women, minor. 7 days for others |
| Section 90 | Admission and treatment of persons with mental illness, with high support needs, in mental health establishment, beyond 30 days (supported admission beyond 30 days) | Nominated representative and permission from MHRB | Inform the board within 7 days |
MHRB – Mental Health Review Board; PMI – Person with mental illness
Figure 1Informed consent for admission and treatment as per Mental Healthcare Act
An informed consent form for clinical research must include the following: As per the Indian Council of Medical Research guidelines
| • Statement mentioning that it is research |
| • Purpose and methods of the research in simple language |
| • Expected duration of the participation and frequency of contact with estimated number of participants to be enrolled, types of data collection, and methods |
| • Benefits to the participant, community, or others that might reasonably be expected as an outcome of research |
| • Any foreseeable risks, discomfort, or inconvenience to the participant resulting from participation in the study |
| • Extent to which confidentiality of records could be maintained, such as the limits to which the researcher would be able to safeguard confidentiality and the anticipated consequences of breach of confidentiality |
| • Payment/reimbursement for participation and incidental expenses depending on the type of study |
| • Free treatment and/or compensation of participants for research-related injury and/or harm |
| • Freedom of the individual to participate and/or withdraw from research at any time without penalty or loss of benefits to which the participant would otherwise be entitled |
| • The identity of the research team and contact persons with addresses and phone numbers (for example, Principal Investigator (PI)/Co-PI for queries related to the research and Chairperson/Member Secretary/or helpline for appeal against violations of ethical principles and human rights). |
| • Any alternative procedures or courses of treatment that might be as advantageous to the participant as the ones to which she/he is going to be subjected |
| • If there is a possibility that the research could lead to any stigmatizing condition, for example, HIV and genetic disorders, provision for pretest and posttest counseling |
| • Insurance coverage if any, for research-related or other adverse events |
| • Foreseeable extent of information on possible current and future uses of the biological material and of the data to be generated from the research. Other specifics are as follows: |
| i. Period of storage of the sample/data and probability of the material being used for secondary purposes |
| ii. Whether material is to be shared with others, this should be clearly mentioned |
| iii. Right to prevent use of her/his biological sample, such as DNA, cell-line, and related data at any time during or after the conduct of the research |
| iv. Risk of discovery of biologically sensitive information and provisions to safeguard confidentiality |
| v. Post research plan/benefit sharing, if research on biological material and/or data leads to commercialization |
| vi. Publication plan, if any, including photographs and pedigree charts[ |
Figure 2Protocol for the care of Homeless Person with Mental Illness
General guidelines to follow while obtaining an informed consent[26]
| • Assessment of mental capacity to consent has to be done |
| • Consent process should be done in a comfortable environment, ideally in the presence of the nominated representative or a neutral witness |
| • Ensure that the person is consenting out of free will with no coercion, persuasion, and undue pressure from either the doctor, family members, nominated representative (NR), or others |
| • Adequate information about the nature of mental illness, the proposed treatment plan, including its rationale, the known side effects of the proposed treatment, prognosis, and natural progression of the disorder with and without the treatment offered, criteria of admission, and related provision/section of the Mental Healthcare Act (MHCA) 2017 has to be provided |
| • It is not sufficient to state that “the risks and benefits were discussed” without further description of the specifics |
| • Clinician should hold a neutral position while discussing about the treatment options |
| • Clinician should encourage person with mental illness (PMI) to discuss his/her concern about treatment and care |
| • Clinician should uphold the individual autonomy of PMI during the consenting procedure |
| • The treatment options offered should be in accordance with the good practice guidelines and evidence-based medicine. |
| • Information about the alternatives to the offered treatment, its risks, consequences, and costs have to be clearly mentioned |
| • The person needs to understand that the result/outcome of the treatment/procedure cannot be guaranteed and more so to their expectations. The person should also be informed that if immediate life-threatening events happen during the treatment/procedure, it will be treated accordingly |
| • The person has to be educated about the right to refusal of treatment and the right to withdraw consent |
| • The person needs to be informed that they have a right to opt for second/more medical opinion |
| • Authorization for procedural photographs/videos for academic purposes (keeping identity confidential) should be obtained. If the person does not authorize for the same, his/her wishes should be respected |
| • In case of admission, the person has to be familiarized with the infrastructure of the mental health establishment and its rules |
| • He/she should receive the information in a language and form that such person receiving the information can understand |
| • The person has to be given adequate time to contemplate and decide on the options offered |
| • The consent has to be clearly documented in the language the person understands, preferably in his/her own writing |
| • If a person is illiterate, consent form has to be read out in the language he/she understands, and the process has to be videographed. Alternatively, a |
| nominated representative or a legally appointed representative can read out the form and sign for the person. A thumb impression of the consenting person has to be recorded on the informed consent form (ICF) |
| • Signatures of the consenting person, witness, and the person conducting the process have to be documented. Any consent without the signature of the medical practitioner will be considered invalid by the law |
| • In case the consenting person is a minor, the consent has to be obtained from the parent/guardian/NR as per Section 87 of the MHCA, 2017 |
| • If the minor attains the age of 18 during his/her stay in the MHE, then the consent has to be obtained from the person and admission under Section 86 of MHCA has to be done |
| • The person needs to be informed about the estimated cost of the treatment/procedure involved in ordinary circumstances |
| • The person needs to understand that, in case of emergency during the agreed treatment/procedure (s) were to arise, the doctor will undertake such other treatment/procedure(s) as necessitated, keeping in mind their best interest, without necessarily seeking any proxy consent |
| • A copy of the informed consent form has to be given to the person, with the original form filed in the patient’s records; it is advisable to have a hard copy in places where consent process is digitalized |
| • Audio/videographic recording of the consent process can be done after informing the same to the consenting person. If they refuse, their wishes have to be honored and the resistance documented |
| • The date and time of the consent procedure have to be recorded in the ICF and questions asked by the person or concerns raised have to be documented in the ICF |